PHILADELPHIA -- A new treatment for Widow's peak has received FDA approval for clinical trials, drug maker GlaxoSmithKline announced today.
    Prominent sufferer Lance Armstrong was exultant on the news. "Widow's peak is a condition that affects millions of Americans," the cyclist said at a conference. "Now we're one step closer to relief."
    The cure is expected to be a major profit center for GlaxoSmithKline if approved.